Low etanercept concentrations in children with obesity and juvenile idiopathic arthritis

Journal Article (Journal Article)

OBJECTIVE To evaluate the impact of obesity on etanercept (ETN) drug exposure in children with juvenile idiopathic arthritis (JIA). METHODS We conducted a pilot, cross-sectional, observational study in a real-world cohort of children with JIA receiving ETN as standard of care from a single center. We analyzed the relationship between body size and ETN plasma concentrations, adjusting for dosage. Body size was analyzed as a continuous measure using weight and body mass index (BMI) percentiles and categorically using BMI percentile classifications according to the CDC guidelines. RESULTS We enrolled a total of 29 children. Each child provided one plasma sample for ETN concentration measurement, and all participants were receiving subcutaneous ETN dosed weekly. We observed that the ETN concentration normalized for dose decreased significantly as a function of weight (p = 0.004) and BMI percentile (p = 0.04). Similarly, we observed a progressive decline in mean and median dose-normalized concentrations across higher body size categories. Because of reaching maximum ETN dosage (50 mg), 7 of 8 children (87.5%) with obesity received a weight-based dosage < 0.8 mg/kg/dose. CONCLUSIONS We found that higher body weight and BMI percentile are significantly and negatively associated with ETN drug serum concentration, accounting for differences in dosing. Our data suggest that children who are obese may be routinely under-dosed using current dosing strategies. Inadequate dosing may increase the risk for therapeutic failure and long-term morbidity in a developing child. As a result, characterizing adequate drug exposure in children of all sizes is an important step toward precision dosing. ABBREVIATIONS ADA, anti-drug antibodies; BMI, body mass index; CDC, Centers for Disease Control and Prevention; ETN, etanercept; JIA, juvenile idiopathic arthritis; TNF-α, tumor necrosis factor–alpha.

Full Text

Duke Authors

Cited Authors

  • Balevic, SJ; Becker, ML; Gonzalez, D; Funk, RS

Published Date

  • January 1, 2021

Published In

Volume / Issue

  • 26 / 8

Start / End Page

  • 809 - 814

Electronic International Standard Serial Number (EISSN)

  • 2331-348X

International Standard Serial Number (ISSN)

  • 1551-6776

Digital Object Identifier (DOI)

  • 10.5863/1551-6776-26.8.809

Citation Source

  • Scopus